SCHEMBL30878729

SCHEMBL30878729

CSc1ncc2c(C#C[Si](C(C)C)(C(C)C)C(C)C)c(C)c(=O)n(C3CCC(NC(C)=O)CC3)c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.39
JAK1 P23458 2/20 0.39
TTK P33981 2/20 0.35
CDK4 P11802 15/20 0.34
CCND1 P24385 14/20 0.34
CCND3 P30281 12/20 0.34
CDK6 Q00534 11/20 0.34
CDK2 P24941 3/20 0.34
CCNT1 O60563 2/20 0.34
CDK9 P50750 2/20 0.34
CDK1 P06493 1/20 0.34
CCNE1 P24864 1/20 0.34
CCND2 P30279 3/20 0.33
MAPK8 P45983 1/20 0.31
MAPK9 P45984 1/20 0.31
MAPK10 P53779 1/20 0.31
FGFR1 P11362 2/20 0.30
CCNA2 P20248 2/20 0.30
FGFR2 P21802 2/20 0.30
FGFR4 P22455 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878684 0.91 JAK2 (0.36) JAK2JAK1TTKCDK4CCND1
SCHEMBL30878713 0.86 CDK4 (0.38) JAK2JAK1TTKCDK4CCND1
SCHEMBL30878702 0.84 TTK (0.40) JAK2JAK1TTKCDK4CCND1
SCHEMBL30878992 0.79 TTK (0.53) TTKCDK4CCND1CCND3CDK6
SCHEMBL30879173 0.77 PIM1 (0.31) TTK
SCHEMBL30878785 0.77 TTK (0.42) JAK1TTKCDK4CCND1CCND3
SCHEMBL30879078 0.76 TTK (0.43) JAK2JAK1TTKMAPK8MAPK9
SCHEMBL30878965 0.74 TTK (0.37) JAK2JAK1TTKMAPK8MAPK9
SCHEMBL30878735 0.74 JAK1 (0.38) JAK2JAK1TTKCDK4CCND1
SCHEMBL30879312 0.74 TTK (0.36) JAK2JAK1TTKMAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed